The problem is, the rest of us haven't necessarily gotten the message. It’s called phenylephrine, and it’s found in a lot of ...

It’s been one year since advisers to the Food and Drug Administration unanimously concluded that phenylephrine — a ...

The Food and Drug Administration (FDA) announced Wednesday its proposal to halt use of oral phenylephrine, an ingredient found in many cough and cold medicines, after concluding that the oral ...

But the pool may be about to get smaller. The U.S. Food and Drug Administration (FDA) announced that it plans to ban products containing phenylephrine, an ingredient found in many over-the-counter ...

Many of the UK’s top brands including Lemsip could be withdrawn from sale after a ruling in the US that a key ingredient found in them, phenylephrine, a decongestant, may be ineffective.

The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may prompt Canada to review its approval of the drug.

Although phenylephrine received FDA approval for over-the-counter use in the 1970s, its popularity surged in 2005 after legislation moved products that use a similar decongestant, pseudoephedrine ...

FDA reported that, for now, companies can continue to market OTC monograph drug products containing oral phenylephrine as a ...

The Food and Drug Administration proposed that oral phenylephrine be removed from store shelves becasue the treatment does not work. Phenylephrine is found in over-the-counter decongestants such ...

The Food and Drug Administration has proposed ending the use of oral phenylephrine, a common ingredient found in many cold and allergy medicines — and some pharmacies already are yanking the ...

Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its job at "unstuffing" when taken by mouth. Jessica is a writer on the ...

Some over-the-counter medications can be used to treat symptoms of the common cold. But not all of them are effective.